Mutations of MTIF2, FASTKD5, and RMND1 in patients have not yet been reported, but MTIF2 was implicated in conduct disorders and in aminoglycoside-induced deafness (see GeneCards database, https://www.genecards.org/; last accessed on 5 July 2022). This evidence concerns the gene MTIF2 and conduct disorder.